These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2719057)

  • 1. Analysis of the quantitative relationship between anemia and chronic renal failure.
    Howard AD; Moore J; Welch PG; Gouge SF
    Am J Med Sci; 1989 May; 297(5):309-13. PubMed ID: 2719057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
    Ifudu O; Dawood M; Friedman EA
    Nephron; 1997; 77(3):315-8. PubMed ID: 9375826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia: an early complication of chronic renal insufficiency.
    Kazmi WH; Kausz AT; Khan S; Abichandani R; Ruthazer R; Obrador GT; Pereira BJ
    Am J Kidney Dis; 2001 Oct; 38(4):803-12. PubMed ID: 11576884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure.
    Ishimura E; Nishizawa Y; Okuno S; Matsumoto N; Emoto M; Inaba M; Kawagishi T; Kim CW; Morii H
    J Nephrol; 1998; 11(2):83-6. PubMed ID: 9589379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.
    McGonigle RJ; Wallin JD; Husserl F; Deftos LJ; Rice JC; O'Neill WJ; Fisher JW
    J Lab Clin Med; 1984 Dec; 104(6):1016-26. PubMed ID: 6501997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of erythropoietin on urinary liver-type fatty-acid-binding protein in patients with chronic renal failure and anemia.
    Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H
    Am J Nephrol; 2006; 26(3):276-80. PubMed ID: 16772708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anemia in patients with chronic renal failure].
    Prejac M; Antos M; Jeren B
    Lijec Vjesn; 1975 Nov; 97(10):556-60. PubMed ID: 1223566
    [No Abstract]   [Full Text] [Related]  

  • 9. [Subcutaneous administration of recombinant human erythropoietin (R-EPO) in the treatment of anemia in predialysis patients with chronic renal failure].
    Debska-Slizień A; Rutkowski B; Niemierko J; Jankowska-Gan E; Gołebiewska-Zurkowska G; Kabata J; Manitius A
    Pol Arch Med Wewn; 1991 Jun; 85(6):334-40. PubMed ID: 1896396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin.
    Eschbach JW; Kelly MR; Haley NR; Abels RI; Adamson JW
    N Engl J Med; 1989 Jul; 321(3):158-63. PubMed ID: 2747747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
    Sanaka T; Akizawa T; Koide K; Koshikawa S
    Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum ferritin levels are increased in patients with acute renal failure.
    Mavromatidis K; Fytil C; Kynigopoulou P; Fragia T; Sombolos K
    Clin Nephrol; 1998 May; 49(5):296-8. PubMed ID: 9617492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal replacement therapy in an animal model with chronic renal failure and gonadectomy: biochemical and hematological study.
    Ali BH; Ahmed IH
    Ren Fail; 2006; 28(4):331-5. PubMed ID: 16771249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frequency of anaemia and indications for treatment with epoetin in chronic renal failure at the pre-dialysis stage].
    Jungers PY; Nguyen-Khoa T; Joly D; Choukroun G; Massy ZA; Jungers P
    Presse Med; 2003 Feb; 32(5):212-6. PubMed ID: 12610461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silicon level in rats with chronic renal failure produced by 5/6 nephrectomy.
    Hosokawa S; Yoshida O
    Nephron; 1995; 69(3):301-4. PubMed ID: 7753264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group.
    Kulzer P; Schaefer RM; Krahn R; Schaefer L; Heidland A
    Int J Artif Organs; 1994 Apr; 17(4):195-202. PubMed ID: 8070941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reasons for producing guidelines on anemia of chronic renal failure: dialysis outcome quality initiative of the National Kidney Foundation.
    Triolo G; Canavese C; Di Giulio S
    Int J Artif Organs; 1998 Nov; 21(11):751-6. PubMed ID: 9894755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of renal anemia in progression of chronic kidney disease].
    Racki S; Maleta I
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():33-7. PubMed ID: 20235353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia in CKD: prevalence, diagnosis, and treatment. Case study of the anemic patient.
    Kammerer J; Ratican M; Elzein H; Mapes D
    Nephrol Nurs J; 2002 Aug; 29(4):371-4. PubMed ID: 12224371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.